Enter your email address to receive notifications of new posts by email.
$TROV Trovagene Prices $4.5 Million Public Offering https://t.co/6hp5Hgbe9Labout 19 hours ago
$CBIO Catalyst Biosciences Announces Appointment of Edward Williams to its Board of Directors https://t.co/L8ngjkuonN5:14 PM Dec 14th
$TROV Trovagene Submits Protocol to FDA for Phase 2 Clinical Trial of PCM-075 in Combination with Zytiga® for Metas… https://t.co/JcyiwmHSte5:13 PM Dec 14th
$ONCS OncoSec Announces Dosing of First Patient in Registration-Directed Phase 2b Clinical Trial, PISCES/KEYNOTE-69… https://t.co/GSaoy04ajt5:05 PM Dec 14th
$CRCW The Crypto Company Announces 10-For-1 Stock Split After Rapid Growth https://t.co/qCVxxKEu9r5:04 PM Dec 14th
Get every new post delivered right to your inbox.